Atlas FDA

POLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, Accessories

FDA premarket approval P220032/S006 · decided 2024-07-05

Approval details

PMA number
P220032
Supplement
S006
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
POLARx/POLARx FIT Cryoablation Catheters, SMARTFREEZE Cryoablation Console, Accessories
Generic name
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Applicant
Boston Scientific Corporation
Date received
2024-06-05
Decision date
2024-07-05
Days to decision
30 days
Decision code
APPR
Product code
OAE
Advisory committee
Cardiovascular
Expedited review
No
Location
St Paul, MN
Statement
approval of the revised protocol (Version F) for the post-approval study (PAS) protocol submitted to comply with the conditions of approval outlined in our approval order for P220023

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27